Ching-Wei David Tzeng MD FACS
Hepatobiliary Surgery, Pancreas
Associate Professor
Join to View Full Profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Fax+1 713-745-1921
Dr. Tzeng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, HPB Surgery, 2012 - 2013- University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2010 - 2012
University of Alabama Medical CenterResidency, Surgery, 2003 - 2010
University of Alabama School of MedicineClass of 2003
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2026
GA State Medical License 2023 - 2026
TN State Medical License 2023 - 2026
TX State Medical License 2010 - 2026
WA State Medical License 2023 - 2026
AL State Medical License 2005 - 2025
American Board of Surgery Surgery- Join now to see all
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery Start of enrollment: 2019 Feb 28
- Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases Start of enrollment: 2022 Nov 16
Roles: Principal Investigator, Contact
- 5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial Start of enrollment: 2024 Mar 27
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- ASO Visual Abstract: Associations of KRAS Point Mutations with Survival in Patients who Underwent Curative-Intent Resection of Colorectal Liver Metastases.Harufumi Maki, Reed I Ayabe, Antony Haddad, Yujiro Nishioka, Timothy E Newhook
Annals of Surgical Oncology. 2025-05-01 - 1 citationsSoftware-based versus visual assessment of the minimal ablative margin in patients with liver tumours undergoing percutaneous thermal ablation (COVER-ALL): a randomise...Bruno C Odisio, Jessica Albuquerque, Yuan-Mao Lin, Brian M Anderson, Caleb S O'Connor
The Lancet. Gastroenterology & Hepatology. 2025-05-01 - Parenchymal-Sparing Hepatectomy versus Single-Stage Major Hepatectomy for Bilateral Colorectal Liver Metastases: A Higher Rate of Microscopically Positive Margins Is N...Mateo Lendoire, Harufumi Maki, Antony Haddad, Anish J Jain, Hop S Tran Cao
Journal of Gastrointestinal Surgery. 2025-04-23
Journal Articles
- Assessing the 5×-Multiplier Calculation to Reduce Discharge Opioid Prescription Volumes After Inpatient SurgeryRyan W Day, Timothy E Newhook, Ching-Wei D Tzeng, JAMA Surgery
- Response and Survival Associated with First-Line FOLFIRINOX vs Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal AdenocarcinomaShubham Pant, Milind Javle, Naruhiko Ikoma, Ching-Wei Tzeng, Jeffrey E Lee, JAMA Surgery
Authored Content
- Response and Survival Associated with First-Line FOLFIRINOX vs Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal AdenocarcinomaJuly 2020
- Response and Survival Associated with First-Line FOLFIRINOX vs Gemcitabine and Nab-Paclitaxel Chemotherapy for Localized Pancreatic Ductal AdenocarcinomaJuly 2020
Press Mentions
Opioid-Free Discharge Feasible After PancreatectomySeptember 9th, 2023- Liver Regeneration: How the Liver’s Ability to Recover Plays into Liver Cancer SurgeryNovember 2nd, 2023
Professional Memberships
- Member
External Links
- Faculty Websitehttp://faculty.mdanderson.org/Ching-Wei_Tzeng/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
